1 rescue of the clinical phenotype amenable to somatic gene therapy.

2 ents, and to develop and test strategies for somatic gene therapy.

3 d the development of efficient protocols for somatic gene therapy.

4 the potential to be an important vehicle for somatic gene therapy.

5 reating an inherited retinal degeneration by somatic gene therapy.

6 , gene expression, adoptive cell therapy and somatic gene therapy.

7           We investigated the application of somatic gene therapy by use of a gibbon-ape-leukaemia-vi

8 constructs may be effective in a strategy of somatic gene therapy for a dominant negative/gain of fun

9                                              Somatic gene therapy for the treatment of dyslipidemia i

10                                              Somatic gene therapy has been proposed as a means to ach

11 Thus, our study demonstrated the efficacy of somatic gene therapy in a mouse model of CMD.

12                                              Somatic gene therapy is a promising approach for treatin

13 ns for the development of new strategies for somatic gene therapy of dominant genodermatoses.

14                                              Somatic gene therapy of hemoglobinopathies depends initi

15 ional IL-33 blockade by locally administered somatic gene therapy reduces T cell infiltrates and impr

16                                              Somatic gene therapies require targeted transfer of the

17                                     Ideally, somatic gene therapy should result in lifetime reversal

18 s not feasible using current strategies, but somatic gene therapy, targeting G6Pase to the liver and

19                                              Somatic gene therapy will require efficient, scale-indep